AstraZeneca’s lung cancer drug combination gets EU approval
HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from
HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from
HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European
HQ Team April 4, 2025: Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development
HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating
HQ Team April 3, 2025: Siemens AG will acquire US, Boston-based Dotmatics for $5.1 billion from Insight Partners to expand its digital life
HQ Team April 2, 2025: Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according
HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from
HQ Team April 1, 2025: Aardvark Weather, an artificial intelligence weather predicting system, can deliver accurate forecasts tens of times faster and using